Bharat Biotech inks MoU with University of Sydney Infectious Diseases Institute

Hyderabad: Bharat Biotech International Limited and the University of Sydney Infectious Diseases Institute (Sydney ID) announced on Tuesday a Memorandum of Understanding (MoU) to advance vaccine research initiatives, strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.

This agreement aims to build strong sectoral collaborations to design novel methodologies to tackle future epidemics and infectious diseases. Additionally, it would leverage academia-industry strengths for advancing the science of vaccines and biotherapeutics.

Dr Krishna Ella, Executive Chairman, Bharat Biotech said, "This agreement reflects our ethos to facilitate collaborative research, foster innovation, and further advance the science vaccine technology. Most importantly, build the talent of young scientists with a passion to innovate.”

Emphasising the significance of the collaboration, Professor Jamie Triccas, Deputy Director, Sydney ID, said, "Positioning Sydney ID on a global scale to drive innovation and highlight our expertise in the development of new vaccines and biotherapeutics is paramount. The reputational and societal impacts of developing novel vaccines to eradicate human and animal diseases that are safe, affordable, and effective cannot be overstated. Together with Bharat Biotech International Limited, we aim to make a lasting impact on global health."